We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.62B
AUM Growth
-$2.78B
Cap. Flow
-$2.47B
Cap. Flow %
-43.88%
Top 10 Hldgs %
56.27%
Holding
465
New
101
Increased
59
Reduced
84
Closed
204

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$44.1M
2
HRMY icon
Harmony Biosciences
HRMY
+$36.9M
3
TVTX icon
Travere Therapeutics
TVTX
+$33.9M
4
MDLN
Medline Inc
MDLN
+$22.4M
5
META icon
Meta Platforms (Facebook)
META
+$20.9M

Top Sells

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$70.6M
2
IMVT icon
Immunovant
IMVT
+$56.5M
3
XRAY icon
Dentsply Sirona
XRAY
+$53.6M
4
GEHC icon
GE HealthCare
GEHC
+$53.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Technology 7.29%
3 Consumer Discretionary 4.25%
4 Communication Services 1.58%
5 Consumer Staples 1.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
76
PUT
Cytokinetics
CYTK
$10.9B
$13.2M 0.23%
+200,000
New +$12.7M
GSK icon
77
GSK
GSK
$104B
$13M 0.23%
236,000
-764,000
-76% -$41.4M
TER icon
78
Teradyne
TER
$50.5B
$13M 0.23%
43,932
+15,630
+55% +$4.36M
CROX icon
79
Crocs
CROX
$6.81B
$12.8M 0.23%
154,593
-35,757
-19% -$3.06M
NKE icon
80
Nike
NKE
$64.9B
$12.5M 0.22%
236,540
-158,169
-40% -$9.59M
BMY icon
81
Bristol-Myers Squibb
BMY
$124B
$12.4M 0.22%
205,024
-167,442
-45% -$9.76M
VERA icon
82
Vera Therapeutics
VERA
$2.76B
$12M 0.21%
298,164
-355,632
-54% -$15.3M
BBOT
83
BridgeBio Oncology
BBOT
$686M
$11.9M 0.21%
1,328,000
+328,000
+33% +$3.52M
CPRI icon
84
Capri Holdings
CPRI
$1.88B
$11.6M 0.21%
+658,000
New +$13.9M
NBIS
85
Nebius Group N.V.
NBIS
$45.1B
$11.2M 0.2%
108,000
-159,421
-60% -$15.9M
XERS icon
86
Xeris Biopharma Holdings
XERS
$1.52B
$11.1M 0.2%
+1,909,838
New +$12.7M
ESPR
87
DELISTED
Esperion Therapeutics
ESPR
$10.8M 0.19%
+3,930,125
New +$12.4M
IQV icon
88
IQVIA
IQV
$34.4B
$10.4M 0.18%
+60,884
New +$11.9M
ROST icon
89
Ross Stores
ROST
$74.9B
$10.4M 0.18%
47,908
-63,126
-57% -$12.6M
NVDA icon
90
NVIDIA
NVDA
$4.91T
$10.3M 0.18%
59,269
-4,686
-7% -$860K
SGMO
91
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$9.97M 0.18%
+40,400,067
New +$16.1M
INTC icon
92
Intel
INTC
$478B
$9.88M 0.18%
223,995
+101,059
+82% +$4.63M
APP icon
93
Applovin
APP
$143B
$9.72M 0.17%
24,422
+2,160
+10% +$1.04M
WDAY icon
94
Workday
WDAY
$35.8B
$9.61M 0.17%
73,995
-19,898
-21% -$3.16M
RDDT icon
95
Reddit
RDDT
$34.9B
$9.43M 0.17%
70,000
-6,600
-9% -$1.12M
NPCE icon
96
Neuropace
NPCE
$548M
$9.1M 0.16%
692,000
-100,000
-13% -$1.5M
ZURA icon
97
Zura Bio
ZURA
$518M
$8.97M 0.16%
1,507,000
-53,000
-3% -$320K
PEGA icon
98
Pegasystems
PEGA
$5.37B
$8.96M 0.16%
210,429
+78,435
+59% +$3.64M
GNRC icon
99
Generac Holdings
GNRC
$12.7B
$8.77M 0.16%
+44,902
New +$8.62M
TMCI icon
100
Treace Medical Concepts
TMCI
$279M
$8.53M 0.15%
6,364,000
– –
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Armistice Capital held 465 positions worth $5.62B, down 33% from $8.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Armistice Capital withdrew a net $2.47B in Q1 2026, closing 204 positions and reducing 84 holdings. Its most notable exit was argenx, an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in UnitedHealth worth $40M.

  • Armistice Capital's largest Q1 2026 buy was UnitedHealth: 148,000 shares worth $40M.
  • Armistice Capital added most to Harmony Biosciences in Q1 2026, an estimated $36.9M increase.
  • Armistice Capital's biggest Q1 2026 reduction was Kenvue, cutting an estimated $70.6M.
  • Armistice Capital fully exited argenx in Q1 2026, selling an estimated $48.8M.
  • Armistice Capital's ten largest holdings make up 56% of its $5.62B portfolio in Q1 2026.
  • Armistice Capital opened 101 new positions and closed 204 in Q1 2026.
  • Armistice Capital's portfolio value fell 33% quarter-over-quarter to $5.62B.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.